How are energy investors positioned?
DALLAS - Enhabit , Inc. (NYSE:EHAB), a leading home health and hospice provider, saw its shares rise 2.5% after reporting fourth quarter results and issuing strong 2025 earnings guidance that topped analyst expectations.
The company reported adjusted earnings per share of $0.04 for Q4, missing the analyst consensus of $0.06. Revenue came in at $258.2 million, below estimates of $262.12 million and down 0.9% YoY.
However, Enhabit provided an optimistic outlook for fiscal 2025, projecting adjusted earnings per share of $0.41-$0.51, well above the $0.29 consensus. The company expects revenue of $1.05-1.08 billion for the year, in line with analyst estimates of $1.07 billion.
"Enhabit is exiting 2024 having executed specific strategies that set us up for long-term growth in both our home health and hospice segments," said CEO Barb Jacobsmeyer.
While home health revenue declined 4.3% YoY to $200.4 million, hospice revenue grew 13.1% to $57.8 million. The company noted its hospice segment exited 2024 with its highest average daily census since spinning off, increasing sequentially every month since January 2024.
Enhabit reduced its bank debt by $10 million in Q4, bringing total 2024 debt reduction to $40 million. The company also opened three new hospice locations in the quarter.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.